SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-20-000879
Filing Date
2020-06-15
Accepted
2020-06-15 17:36:17
Documents
1
Period of Report
2020-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3811
  Complete submission text file 0001123292-20-000879.txt   5313
Mailing Address C/O SPIROS DEVELOPMENT CORP II INC 7475 LUSK BLVD SAN DIEGO CA 92121
Business Address
KABAKOFF DAVID S (Reporting) CIK: 0001024008 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38905 | Film No.: 20964359
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Issuer) CIK: 0001661059 (see all company filings)

IRS No.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations